VTRS
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
2024-03-01–present
Equibles does not estimate personal net worth.
Get an email with a short summary when Viatris Inc publishes a filing, an earnings call transcript or a press release.
Get VTRS alertsTheodora (Doretta) Mistras is recorded as CFO at Viatris Inc (VTRS) since March 1, 2024. Viatris Inc reported in an 8-K filed December 15, 2023 that Theodora (Doretta) Mistras was appointed Chief Financial Officer, effective March 1, 2024. Viatris Inc is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Viatris Inc includes Scott A. Smith (CEO and Board Member), Robert J. Coury (Chairman and Board Member), Sanjeev Narula (CFO) and 7 others.
“On December 14, 2023, the Company appointed Theodora (Doretta) Mistras to serve as the Chief Financial Officer of the Company, effective as of March 1, 2024, and to hold such office until her successor is chosen and qualified in her stead or until her earlier death, resignation or removal.”
2024-03-01–present
VTRS
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
2024-03-01–present